Trial Profile
Tolerability and Pharmacokinetics of a Single 900 mg Oral Dose of BIA 2-093 and Oxcarbazepine in Healthy Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 24 Apr 2015
Price :
$35
*
At a glance
- Drugs Eslicarbazepine acetate (Primary) ; Oxcarbazepine
- Indications Epilepsy
- Focus Pharmacokinetics
- Sponsors Bial
- 24 Apr 2015 New trial record